Cargando…
Treatment of a Refractory Case of Chronic Bullous Disease of Childhood in a Five Year Old Child with Rituximab
Patients with chronic bullous disease of childhood (CBDC) generally respond well to treatment with drugs like Dapsone and oral and topical steroids. Refractory cases are additionally treated with immunosuppressants like azathioprine, methotrexate, ciclosporin, colchicine, tetracycline, and IVIG (Int...
Autores principales: | Agarwal, Uma S., Randhawa, Navneet K., Singh, Arti, Agarwal, Puneet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653733/ https://www.ncbi.nlm.nih.gov/pubmed/34934730 http://dx.doi.org/10.4103/idoj.IDOJ_914_20 |
Ejemplares similares
-
Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab
por: Mitra, Debdeep, et al.
Publicado: (2022) -
Bullous systemic lupus erythematosus in a 10-year-old child
por: Hans-Bittner, Nelise Ritter, et al.
Publicado: (2017) -
Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia
por: Šimkovič, Martin, et al.
Publicado: (2015) -
Successful Treatment of a Bullous Pemphigoid Patient with Rituximab Who Was Refractory to Corticosteroid and Omalizumab Treatments
por: Bilgiç Temel, Aslı, et al.
Publicado: (2017) -
Refractory Bullous Systemic Lupus Erythematosus Successfully Treated with Rituximab: A Case Report and Literature Review
por: Ratanapokasatit, Yanisa, et al.
Publicado: (2023)